#DiscoveryBiology

[eurofinsadvinus]

At Eurofins Advinus, our integrated drug discovery services are designed to help biotech and pharmaceutical companies accelerate their research efficiently and effectively. Our team of experts have the experience and expertise to provide comprehensive support at every stage of the drug discovery process. Partner with us to leverage our proven track record and commitment to excellence. Connect with us at bd@advinus.com Click on the link to know more details about Discovery Services.

[eurofinsadvinus]

Elevate your clinical outcomes with our cutting-edge Molecular Biomarker Panels! 🧬Eurofins Advinus leads the way in Discovery Biology Services, offering tailored solutions for precise clinical predictions. Harness the power of molecular biomarkers to revolutionize your research. Connect with our experts - bd@advinus.com

[eurofinsadvinus]

📣 We are now equipped with Biocore 8K!

Biocore 8K, is a high-throughput, high sensitivity surface plasmon resonance (SPR) system that enables efficient screening, characterization, process optimization, and quality control of small molecules and biotherapeutics.

We are elated to be able to add specialized instruments to offer cutting edge solutions to meet your specific needs. We are committed to delivering exceptional quality and accelerating your drug development process. To know more, connect with us at 📧 bd@advinus.com

[eurofinsadvinus]

As you are aware our state-of-the-art facility in Hyderabad, India is dedicated to Drug Discovery and Development Services. We at Eurofins Advinus are committed to advancing research and making a meaningful impact on healthcare worldwide. From target identification and lead optimization to preclinical development, our Hyderabad facility offers a comprehensive range of integrated drug discovery services. We provide end-to-end solutions that enable our partners to accelerate their research. Our multidisciplinary teams work together seamlessly, ensuring that we deliver the best results for our partners. To connect with our team of experts, please reach out to bd@advinus.com Looking forward to collaborating with you!

[eurofinsadvinus]

Are you concerned with the unwanted challenges associated with immunogenicity to your biotherapeutic(s)? Eurofins Advinus Discovery Services can help assess the potential problems of unwanted immune responses that target your therapeutic peptide, thus preventing fatal consequences. Our team of specialists perform human PBMC based in vitro assays for immunogenicity risk assessment of therapeutic peptides. Immunogenicity assessment of impurities is conducted in GLP conditions as per ICH and USP guidelines. To know more contact us - https://lnkd.in/eDKB93N

[eurofinsadvinus]

Eurofins Advinus Discovery Services team is set to attend Discovery Europe 2023 in Berlin from June 6-7. We would like to invite you to visit us at booth 22. We look forward to sharing our latest advancements in discovery services and explore ways to help advance and accelerate your research. We offer integrated and/or stand-alone drug discovery services that include - Medicinal Chemistry, Analytical Chemistry, In Vitro Biology, Safety Pharmacology Studies and ADME/DMPK. To know more click on the link - https://lnkd.in/dJeKvzGs “It has been observed that fake employment offers are being made, via email and otherwise, by misusing Eurofins Advinus name. Please be informed that Eurofins Advinus does not require any payment or fees from prospective candidates and Eurofins Advinus does not send any recruitment email from generic email addresses other than email addresses ending with “advinus.com”. ”

[eurofinsadvinus]

Worried about innate immune response modulating impurities (IIRMI) in your therapeutic peptides and proteins? Our team is here to help! We offer cell based In-Vitro innate and adaptive immunogenicity assays for evaluating IIRMIs in peptide and protein drug products. Connect with us at 📧 bd@advinus.com.

[eurofinsadvinus]

Looking forward to meeting you at Drug Discovery Chemistry, April 10-13, 2023 at San Diego. If you would like to schedule a meeting email us at bd@advinus.com Eurofins Advinus Discovery Services understands your requirements and ensures high quality and on-time delivery of reports. Our team, with their breadth and depth of knowledge, is able to provide essential insights to advance your projects. With robust processes and utilization of the latest technological tools we advance your integrated or stand-alone drug discovery requirements – Medicinal Chemistry, Analytical Chemistry, In Vitro Biology, Safety Pharmacology Studies and ADME/DMPK. To know more click on the link - https://lnkd.in/dJeKvzGs

[eurofinsadvinus]

Assessing whether products have innate immune response modulating impurities (IIRMI) is a key component of immunogenicity risk assessments. Accurate assessments of immunogenicity risk can aid in the selection, development and regulation if biologics. Our team of experts detect IIRMIs in therapeutic products using high sensitivity TLR assay platform.

[eurofinsadvinus]

Dr. Lalitha Vijayakrishnan and Ms. Pujitha Reddy will be at the ACE Drug Discovery Summit, 2-3 March 2023 at The Insurance Hall, London. Looking forward to fantastic conversations and new potential opportunities. If you will be in the city or at the event and would like to schedule a meeting to discuss your drug discovery and development requirements, email us at bd@advinus.com

[eurofinsadvinus]

Meet our discovery services at the upcoming Discovery Europe Conference. They will be at booth 4 at the Hotel Palace Berlin. Click here for more details - https://lnkd.in/d6HsA8W5 Eurofins Advinus provides stand-alone and fully integrated services for Discovery Chemistry, Discovery Biology and ADMET/ DMPK. https://lnkd.in/dW6Cpr75

[eurofinsadvinus]

Eurofins Advinus has broad drug discovery capabilities and proven experience in delivering a wide variety of integrated projects successfully with respect to the delivery of quality data and on-time performance. To know more, click on the link https://lnkd.in/eDKB93N

[eurofinsadvinus]

Non-alcoholic steatohepatitis (#NASH) models enable us to investigate the disease and are useful for studying the pathways and processes that promote steatohepatitis and fibrosis. Eurofins Advinus has several NASH models to help with preclinical investigations. To speak with our experts, click on the link https://lnkd.in/eDKB93N

[eurofinsadvinus]

Eurofins Advinus offers comprehensive pharmacology services for various therapeutic areas. Our scientists are highly skilled and trained to help advance your drug discovery pharmacology studies. To connect with our specialist, email us at bd@advinus.com.

[eurofinsadvinus]

With state-of-the-art facilities backed with a team of specialists our integrated drug discovery and development services strive to deliver a clinical candidate that meets all the candidate selection criteria and IND ready molecule in the shortest possible time.